Enliven Therapeutics, Inc. — 8-K Filings
50 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 50 8-K documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-088195 | Mar 3, 2026 | — |
| 8-K | 8-K | 0001193125-26-005535 | Jan 7, 2026 | Jan 6, 2026 |
| 8-K | 8-K | 0001193125-25-315196 | Dec 11, 2025 | Dec 9, 2025 |
| 8-K | 8-K | 0001193125-25-277580 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-179837 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-146874 | Jun 25, 2025 | Jun 24, 2025 |
| 8-K | 8-K | 0001193125-25-141085 | Jun 16, 2025 | Jun 13, 2025 |
| 8-K | 8-K | 0001193125-25-140285 | Jun 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-071387 | May 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-038737 | Mar 13, 2025 | — |
| 8-K | 8-K | 0000950170-24-126323 | Nov 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-096204 | Aug 13, 2024 | — |
| 8-K | 8-K | 0001193125-24-163507 | Jun 18, 2024 | — |
| 8-K | 8-K | 0000950170-24-059544 | May 14, 2024 | — |
| 8-K | 8-K | 0001193125-24-092522 | Apr 11, 2024 | — |
| 8-K | 8-K | 0001193125-24-090821 | Apr 9, 2024 | Apr 8, 2024 |
| 8-K | 8-K | 0001193125-24-070839 | Mar 19, 2024 | — |
| 8-K | 8-K | 0000950170-24-031482 | Mar 14, 2024 | — |
| 8-K | 8-K | 0000950170-23-062042 | Nov 9, 2023 | — |
| 8-K | 8-K | 0000950170-23-041322 | Aug 10, 2023 | — |
| 8-K | 8-K | 0001193125-23-174006 | Jun 26, 2023 | Jun 23, 2023 |
| 8-K | 8-K | 0001193125-23-173796 | Jun 23, 2023 | — |
| 8-K | 8-K | 0001193125-23-142019 | May 11, 2023 | — |
| 8-K | 8-K | 0001193125-23-056303 | Mar 1, 2023 | Feb 23, 2023 |
| 8-K | 8-K | 0001193125-23-044902 | Feb 22, 2023 | — |
| 8-K | 8-K | 0001193125-23-036052 | Feb 13, 2023 | — |
| 8-K | 8-K | 0001193125-22-298474 | Dec 5, 2022 | Nov 28, 2022 |
| 8-K | 8-K | 0001193125-22-282630 | Nov 10, 2022 | Nov 9, 2022 |
| 8-K | 8-K | 0001193125-22-262375 | Oct 14, 2022 | Oct 13, 2022 |
| 8-K | 8-K | 0001193125-22-262210 | Oct 13, 2022 | — |
| 8-K | 8-K | 0001193125-22-239422 | Sep 7, 2022 | Sep 6, 2022 |
| 8-K | 8-K | 0001564590-22-027108 | Jul 29, 2022 | Jul 25, 2022 |
| 8-K | 8-K | 0001564590-22-022471 | Jun 3, 2022 | Jun 2, 2022 |
| 8-K | 8-K | 0001564590-22-014494 | Apr 14, 2022 | Apr 5, 2022 |
| 8-K | 8-K | 0001564590-22-010212 | Mar 15, 2022 | — |
| 8-K | 8-K | 0001564590-21-055442 | Nov 9, 2021 | — |
| 8-K | 8-K NOVEMBER | 0001564590-21-051756 | Oct 25, 2021 | Oct 21, 2021 |
| 8-K | 8-K | 0001564590-21-041896 | Aug 6, 2021 | — |
| 8-K | 8-K | 0001193125-21-214740 | Jul 14, 2021 | Jul 13, 2021 |
| 8-K | 8-K | 0001193125-21-214102 | Jul 13, 2021 | — |
| 8-K | 8-K | 0001564590-21-035335 | Jun 30, 2021 | Jun 29, 2021 |
| 8-K | 8-K | 0001564590-21-032551 | Jun 11, 2021 | Jun 8, 2021 |
| 8-K | 8-K | 0001564590-21-026280 | May 11, 2021 | — |
| 8-K | 8-K | 0001193125-21-104184 | Apr 1, 2021 | — |
| 8-K | 8-K | 0001564590-21-011096 | Mar 5, 2021 | — |
| 8-K | 8-K | 0001564590-20-050855 | Nov 5, 2020 | — |
| 8-K | 8-K | 0001564590-20-040169 | Aug 14, 2020 | — |
| 8-K | 8-K | 0001564590-20-022383 | May 7, 2020 | — |
| 8-K | 8-K | 0001193125-20-115876 | Apr 23, 2020 | Apr 22, 2020 |
| 8-K | 8-K | 0001193125-20-074861 | Mar 16, 2020 | — |